ABCB1 and Alzheimer disease: Furthermore, a clinical discovery provided evidence that ABCB1 function, which can be assessed using (R)-[11C] verapamil and positron emission tomography (PET) in vivo, was decreased in AD patients compared with age-matched healthy controls [85].